The important inhibitory role of cFLIP in melanoma against TRAIL-induced apoptosis is further supported by a series of studies in melanoma where manipulating the expression or stability of cFLIP by various experimental means was able to change the sensitivity of melanoma cells to TRAIL accordingly [28,29,30,31,32,33]. The gene discussed is CFLAR; the disease is melanoma.